New diabetes clinical trial: A Study of LY3209590 in Participants With Type 1 Diabetes
Published on: June 29, 2020 at 09:30PM
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: LY3209590; Drug: Insulin Degludec
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/3i9Vj3T
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: LY3209590; Drug: Insulin Degludec
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/3i9Vj3T
Comments
Post a Comment